Skip to main content
Pierrel logo

Pierrel — Investor Relations & Filings

Ticker · PRL ISIN · IT0005549644 LEI · 8156002BC7CB6E3BD403 XMIL Manufacturing
Open in API
Filings indexed 577 across all filing types
Latest filing 2019-01-31 Regulatory Filings
Country IT Italy
Listing XMIL PRL

About Pierrel

https://www.pierrelgroup.com/en/

Pierrel is a global pharmaceutical company specializing in oral health. With over 70 years of experience, the company focuses on the development, production, registration, and licensing of dental anesthetics and complementary medical devices. Its core expertise lies in the aseptic manufacturing of injectable drugs. The product portfolio includes a wide range of dental anesthetics marketed under its own brands, such as Orabloc®, Ubisestin™, Xylestesin™, and Mepivastesin™. In addition to its branded products, Pierrel offers medical devices for oral pathology screening, prevention, and regeneration. The company also provides contract manufacturing services to the pharmaceutical and life science industries. Its production facilities are authorized by major global regulatory agencies, including the EMA and FDA, ensuring compliance with high international quality standards.

Recent filings

Filing Released Lang Actions
Pierrel S.p.A.: Informativa mensile ai sensi dell’articolo 114, comma 5, D. Lgs. n. 58/98
Regulatory Filings Classification · 1% confidence The document is a monthly financial disclosure ('Informativa mensile') issued by Pierrel S.p.A. in compliance with Article 114, paragraph 5 of the Italian Legislative Decree 58/98 (TUF). It provides detailed tables and commentary on the Net Financial Position (NFP) of the Group and the parent company as of December 31, 2018. While it contains financial data, it is a recurring monthly regulatory disclosure rather than a full quarterly or annual report. In the context of the provided categories, this fits best as a Regulatory Filing (RNS) as it is a specific compliance-driven announcement required by the Italian regulator (CONSOB). FY 2018
2019-01-31 Italian
Pierrel S.p.A.: Informativa mensile ai sensi dell’articolo 114, comma 5, D. Lgs. n. 58/98
Interim / Quarterly Report Classification · 1% confidence The document is a monthly financial disclosure ('Informativa mensile') issued by Pierrel S.p.A. in compliance with Article 114, paragraph 5 of the Italian Legislative Decree 58/98 (TUF). It provides detailed tables and commentary on the Net Financial Position (Posizione Finanziaria Netta) of the company and the group for the period ending November 30, 2018. Since it contains substantive financial data and analysis for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). Q4 2018
2018-12-31 Italian
Pierrel S.p.A.: APPROVATO IL CALENDARIO DEGLI EVENTI SOCIETARI PER L’ESERCIZIO 2019
Report Publication Announcement Classification · 1% confidence The document is an official communication from Pierrel S.p.A. (indicated by the metadata headers 'Informazione Regolamentata' and 'Societa' PIERREL') dated December 27, 2018. The subject ('Oggetto') is 'Pierrel S.p.A.: APPROVATO IL CALENDARIO DEGLI EVENTI SOCIETARI PER L'ESERCIZIO 2019'. The content explicitly details the approved schedule of corporate events for the 2019 fiscal year, including dates for board meetings to approve financial statements (annual and interim) and the Shareholders' Meeting for budget approval. This type of announcement, which communicates future scheduled corporate events (like earnings release dates, AGM dates, etc.), is typically classified as a general regulatory announcement or a specific type of corporate event notification. Since it is not the actual financial report (10-K, IR), earnings release (ER), or proxy statement (PSI), but rather an announcement about the schedule of future corporate events, it fits best under the general 'Regulatory Filings' (RNS) category, as it is a mandatory disclosure regarding the company's schedule, or potentially a Report Publication Announcement (RPA) if it were announcing the publication of a report, but here it announces the schedule of future events. Given the options, RNS serves as the best general regulatory disclosure category for scheduled corporate events that don't fit a more specific category like DIV or DVA.
2018-12-27 Italian
Pierrel S.p.A.: Informativa mensile ai sensi dell’articolo 114, comma 5, D. Lgs. n. 58/98
Interim / Quarterly Report Classification · 1% confidence The document is a monthly financial disclosure ('Informativa mensile') issued by Pierrel S.p.A. in compliance with Article 114, paragraph 5 of the Italian Legislative Decree n. 58/98. It provides detailed tables and commentary on the Net Financial Position (PFN) of the Group and the parent company as of October 31, 2018. While it is a recurring disclosure, it contains substantive financial data and analysis of the company's debt and liquidity, distinguishing it from a simple report publication announcement. It fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data for a period shorter than a full fiscal year. Q4 2018
2018-11-30 Italian
Pierrel S.p.A.: PIERREL IN CANADA. ACCORDI CON SINCLAIR E CON INNOMAR
Regulatory Filings Classification · 1% confidence The document is an official communication from Pierrel S.p.A. dated November 20, 2018, regarding significant business agreements (a ten-year private label production/commercialization deal with Sinclair Dental and a new distribution/logistics agreement with Innomar Strategies in Canada). The metadata indicates it is an 'Informazione Regolamentata' (Regulated Information) filed on the MTA market. The content describes strategic business developments and partnerships, which typically fall under general corporate updates or regulatory disclosures. Since it is not a full financial report (10-K, IR), an earnings release (ER), a dividend notice (DIV), or a management discussion (MDA), and it details strategic corporate actions, it best fits the general category for regulatory announcements that don't fit elsewhere, or potentially a Capital/Financing Update (CAP) if the deals involved significant capital structure changes, but the focus here is on commercial agreements and market expansion. Given the nature of announcing major commercial contracts and strategic market entries, and lacking a more specific category like M&A (TAR), the most appropriate general classification for a significant, non-financial-result-focused regulatory disclosure is Regulatory Filings (RNS), as it is a broad disclosure of material, non-standard information.
2018-11-21 Italian
Pierrel S.p.A.: COMUNICAZIONE DI VARIAZIONE DEL CAPITALE SOCIALE
Capital/Financing Update Classification · 1% confidence The document is titled 'COMUNICAZIONE DI VARIAZIONE DEL CAPITALE SOCIALE' (Communication of Share Capital Variation) and explicitly details the change in the number of shares and the total capital before and after an increase ('Aumento di Capitale'). This directly relates to changes in the company's capital structure. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it involves shares, it is a formal communication about the resulting capital structure change, not just a transaction (POS) or a general share issue announcement (SHA), but specifically a post-financing capital structure update.
2018-11-14 Italian

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.